- Prev close
- $410.24
- Day range
- $398.52 – $413.00
- From 52-wk high
- -8.2%
- Next earnings
- in 41 days
AMGN’s latest session was essentially flat at +0.2% while the S&P 500 fell -0.4% and peers were mixed, so the move looks more like routine trading than a stock-specific break. The underlying picture is solid but the PEG of 5.48 shows growth is already priced in, which leaves the setup less forgiving.
AMGN
AMGEN INC
As of Sep 16, 2026
68/100
Worth keeping an eye onHealth ScoreWhy it moved
AMGN moved +0.2% even as the S&P 500 fell -0.4% and the Nasdaq 100 was +0.0%, while same-sector peers were mixed with ABBV -0.2% and GILD +0.9%. That makes the session look mostly market-neutral and sector-mixed rather than driven by a company-specific headline; the intraday path was also tight, with an open of $377.01, a high of $379.11, and a low of $374.46 before closing at $376.35.
Normal volatility?
This looks like ordinary volatility, not a fundamental break: revenue is +9.1% YoY (TTM), the latest quarter was +9.5% YoY, and EPS is +31.7% YoY (TTM), while margins remain strong at gross +74.3%, operating +30.3%, and net +22.9%. Valuation is not cheap with PE 23.3, forward PE 16.9, and PEG 5.48 — a PEG of 5.48 means investors are paying 5.48× the growth rate, so strong growth is already priced in and the stock can still swing without any change in the business. Beta is 0.47, which supports a lower-volatility profile, and the analyst recommendation distribution of 6 strong-positive, 14 positive, 20 neutral, 2 negative, 1 strong-negative is constructive but not unanimous.
Earnings preview
The next earnings date is 2026-11-02. The facts do not provide current consensus revenue or EPS estimates for that print, so I can’t cite a forecasted growth rate or margin expectation this period; they also don’t include a usable history of how AMGN has traded around prior reports. What the market is likely watching is whether revenue growth stays near the recent +9.1% YoY (TTM) / +9.5% YoY latest-quarter pace, whether EPS can keep tracking the +31.7% YoY (TTM) trend, and whether operating margin holds near +30.3%.
This report is for informational and educational purposes only. It does not constitute financial, investment, tax, or legal advice. The platform does not recommend buying or selling any security.
Track AMGN with WhyIHold
Get a plain-English explanation the next time AMGEN INC makes a big move — so you know whether it's benign or worth your attention.